Chiari Malformation & Syringomyelia Case Review Coordination

• Age at symptom onset and chronology of progression.
• Headache location, duration, frequency and relationship to coughing, sneezing, laughing, bending, lifting or straining.
• Presence of migraine features, light or sound sensitivity, nausea, aura or non-strain-related daily headache.
• Neck and limb pain, numbness, altered pain or temperature sensation, weakness, hand clumsiness, stiffness and gait change.
• Balance, vertigo, hearing, visual, swallowing, voice, reflux and sleep-breathing symptoms.
• Bladder, bowel, sexual, autonomic and functional effects where relevant.
• Patient-defined goals and the symptoms they most need clarified.

• Original MRI DICOM files, not only screenshots or a radiology report.
• Sagittal and axial sequences through the posterior fossa, foramen magnum and upper cervical region.
• Radiology reports and dates of all studies.
• Assessment of tonsillar position and shape, posterior fossa crowding, brainstem position and fourth-ventricular outflow.
• Hydrocephalus, intracranial mass, craniosynostosis-related anatomy, signs of intracranial hypotension or hypertension, and other possible causes of secondary descent.
• Comparison with earlier imaging to identify stability or progression.

A single numerical measurement of tonsillar descent should not replace review of the full anatomy and clinical context.

• Cervical, thoracic and lumbar MRI DICOM where clinically available or requested.
• Syrinx or syringobulbia location, length, maximal diameter and cord expansion.
• Comparison over time and relation to symptoms.
• Alternative causes such as tumour, prior trauma, arachnoiditis, infection, tethering or another CSF-flow obstruction.
• Conus level, spinal dysraphism or tethering information where relevant.
• Spinal-cord signal changes and associated deformity.

• Cine or phase-contrast MRI DICOM and report where previously performed.
• Description of ventral and dorsal flow at the foramen magnum.
• Technical details and whether the study was performed before or after surgery.
• Relationship to the overall anatomy and symptom profile.

CSF-flow imaging may add information in selected cases, but it is not a stand-alone diagnostic test or a reliable guarantee of surgical benefit.

• Neurological examination, including cranial nerves, strength, reflexes, sensation, coordination and gait.
• Ophthalmology or neuro-ophthalmology records where visual symptoms or papilloedema are relevant.
• Sleep study where symptoms suggest sleep-disordered breathing.
• Swallow assessment, speech-language or ENT review where dysphagia, aspiration or voice symptoms are present.
• Vestibular, hearing and headache-specialist records where relevant.

Sleep or swallow testing is generally symptom-driven rather than automatically required in every patient with a Chiari finding.

• Pregnancy, birth, developmental and school history.
• Feeding, growth, speech, sleep and motor-development information.
• Serial neurological examinations.
• Standing spinal radiographs, Cobb-angle measurements and orthopaedic plans.
• Curve progression, brace history and relation to syrinx evolution.
• Therapy, rehabilitation and educational-support records.

• Operative report, including extent of suboccipital bone removal and cervical laminectomy.
• Whether the dura was opened, graft type, arachnoid handling, tonsillar reduction or fourth-ventricular exploration.
• Fusion, instrumentation, ventral decompression, shunt or detethering details where applicable.
• Early and later postoperative MRI.
• Change in headache, neurological function and syrinx size.
• CSF leak, pseudomeningocele, meningitis, hydrocephalus, instability, wound or hardware complications.

• CT or MRI showing basilar invagination, odontoid orientation, atlas assimilation, Klippel–Feil anatomy or other bony variation.
• Previously reported clivo-axial angle, pB-C2 or other craniocervical measurements.
• Dynamic imaging where ordered by the specialist team.
• History of connective-tissue disorder, major trauma or prior fusion.
• Neurological signs of ventral brainstem compression or myelopathy.

No single metric, hypermobility diagnosis or dynamic image should be treated as an automatic indication for fusion.

• Major medical conditions, anaesthetic history, anticoagulation and wound-healing risks.
• Current medication and pain-management history.
• Baseline function, employment, school, caregiving and rehabilitation needs.
• Travel fitness and support person availability.
• Access to local neurology, neurosurgery, rehabilitation, sleep, swallow and orthopaedic follow-up.
• Expectations regarding headache, neurological recovery, syrinx reduction and timing.

The term “Arnold–Chiari” has historically been used broadly, but current clinical usage generally refers to Chiari I when discussing isolated cerebellar tonsillar descent in older children or adults. Chiari II is a different congenital condition usually associated with myelomeningocele and hydrocephalus. These pathways should not be presented as increasing grades of the same disease.

Common definitions use a range of tonsillar descent below the foramen magnum, but the threshold is not a stand-alone clinical rule. Some patients with substantial descent are asymptomatic, while selected patients with lesser descent may have crowding, disturbed CSF flow or a syrinx. Review includes tonsillar morphology, posterior fossa anatomy, brainstem position, CSF spaces and the full symptom pattern.

Asymptomatic Chiari I without a syrinx is generally not an indication for prophylactic surgery. Follow-up can be individualized according to age, anatomy, symptoms and clinician judgement. Patients and families should know which new neurological, swallowing, breathing or exertional symptoms warrant reassessment. Routine activity restriction is not automatically supported for an asymptomatic patient without a syrinx; individualized advice may differ when symptoms, syringomyelia or another condition is present.

Occipital or suboccipital headache provoked by coughing, sneezing, laughing or straining is the headache phenotype most consistently associated with improvement after decompression. Migraine, tension-type, cervicogenic and chronic daily headaches can coexist with a Chiari finding and may respond less predictably. Headache assessment should therefore document phenotype and prior headache treatment rather than assume causation from MRI.

A syrinx is a fluid-containing cavity within the spinal cord; extension into the brainstem is termed syringobulbia. Review should document level, diameter, cord expansion, progression and corresponding neurological signs. Symptoms may include weakness, hand dysfunction, altered pain or temperature sensation, stiffness, spasticity, gait change and scoliosis. Syrinx presence can strengthen the relevance of foramen magnum obstruction, but alternative causes must still be considered.

Children may present with headache, scoliosis, developmental or school concerns, feeding difficulty, reflux, swallowing symptoms, sleep-disordered breathing, motor change or a syrinx. The relationship between Chiari decompression and scoliosis progression is variable; age, curve magnitude and syrinx behaviour matter. Orthopaedic and neurosurgical plans should be coordinated rather than assuming decompression alone will correct a spinal deformity.

Tonsillar descent can be secondary to hydrocephalus, an intracranial mass, craniosynostosis, CSF leak or intracranial hypotension, intracranial hypertension, prior craniospinal surgery or other disorders. In these cases, treating the pressure disorder or underlying lesion may take priority over standard posterior fossa decompression. A “pseudo-Chiari” pattern should be actively considered when the clinical and imaging context is atypical.

When Chiari I is identified only on limited brain or cervical imaging, specialist teams may request fuller brain and spinal imaging to assess hydrocephalus, tumour, syringomyelia, tethering or other clinically relevant pathology. Whole-spine imaging is particularly relevant when a syrinx, scoliosis, myelopathy or an alternative spinal cause is suspected.

Cine or phase-contrast MRI can show CSF motion at the foramen magnum and may contribute to selected evaluations, but evidence is mixed regarding its ability to predict benefit from decompression. It should not be used as a stand-alone eligibility test. Upright MRI may be useful in particular specialist questions, but is not routinely required and should not replace high-quality conventional imaging, neurological assessment or review of alternative diagnoses.

For carefully selected symptomatic Chiari I patients, posterior fossa or foramen magnum decompression aims to relieve crowding and improve CSF pathways. Strain-related headache is among the more predictable symptoms; other symptoms may improve variably. Surgery does not guarantee resolution of every headache, reversal of established spinal-cord injury, normalization of all imaging findings or permanent freedom from recurrence.

Bone decompression without opening the dura and decompression with dural opening and duraplasty are both used as first-line approaches in selected patients. Bone-only surgery may reduce CSF-related surgical exposure but can be insufficient in some cases. Duraplasty may provide greater intradural expansion and may support syrinx improvement in selected patients, while increasing the potential for CSF leak, pseudomeningocele, meningitis and related complications. Current evidence does not support one technique as universally superior for every patient.

Reduction or resection of cerebellar tonsil tissue, arachnoid dissection or exploration of fourth-ventricular outflow may be considered in selected cases, particularly when a significant syrinx is present or obstruction persists. These are not routine requirements for all patients and can add intradural risk. The choice depends on anatomy, prior surgery, centre experience and intraoperative findings.

Syrinx reduction may take months and does not always parallel symptom improvement. Persistent or enlarging syringomyelia requires review of the adequacy of decompression, CSF obstruction, arachnoid scarring, instability, hydrocephalus, tethering, tumour or another cause. In stable patients, specialist teams commonly allow time for postoperative evolution before considering revision. Direct syrinx shunting is generally a selected secondary strategy rather than an automatic first step.

Basilar invagination, retroflex odontoid, atlas assimilation, Klippel–Feil anatomy and ventral brainstem compression can alter surgical planning. Measurements such as the clivo-axial angle or pB-C2 may contribute to assessment, but no single metric proves instability or mandates fusion. Stabilization is not a routine addition to Chiari decompression and should be reserved for carefully selected patients with convincing anatomical, dynamic and clinical evidence.

Hypermobility or a connective-tissue diagnosis may influence anaesthetic, wound, instability and rehabilitation planning, but does not by itself establish that symptoms are caused by Chiari or that fusion is required. Labels such as “Chiari 0” or “Chiari 1.5,” dynamic imaging findings, or a proposed occult tethered-cord diagnosis should be interpreted within the complete clinical and anatomical context.

Routine sectioning of the filum terminale is not an established treatment for standard Chiari I malformation in the absence of a separately supported tethered-cord indication. The potential benefits, uncertainty and irreversible risks of any non-standard pathway require specialist review and explicit informed consent.

Chiari II is usually associated with open spinal dysraphism and hydrocephalus and can involve the cerebellum, brainstem and lower cranial nerves. New swallowing, breathing, voice or upper-limb symptoms can be urgent. Shunt malfunction or hydrocephalus should be assessed promptly because it may contribute to deterioration. Management belongs in an experienced multidisciplinary spina bifida and pediatric neurosurgical pathway rather than a routine Chiari I treatment funnel.